<html>
<head>PUBMED IDs for CERS2</head>
<body bgcolor='#C5F0F2'><h1>CERS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20937905/'>ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22579584/'>A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells.</a> November 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23585552/'>Genome-wide association study identifies genetic risk underlying primary rhegmatogenous retinal detachment.</a> February 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25213553/'>CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.</a> March 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25238615/'>A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND.</a> June 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27775668/'>Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.</a> October 25  2016<br></body></html>
